These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2140899)

  • 1. Comparative serotonin neurotoxicity of the stereoisomers of fenfluramine and norfenfluramine.
    Johnson MP; Nichols DE
    Pharmacol Biochem Behav; 1990 May; 36(1):105-9. PubMed ID: 2140899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of repeated oral versus subcutaneous fenfluramine administration on rat brain monoamine neurons: pharmacokinetic and dose-response data.
    De Souza EB; Zaczek R; Culp S; Appel NM; Contrera JF
    Pharmacol Biochem Behav; 1991 Aug; 39(4):963-9. PubMed ID: 1763116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (+)-Fenfluramine and its major metabolite, (+)-norfenfluramine, are potent substrates for norepinephrine transporters.
    Rothman RB; Clark RD; Partilla JS; Baumann MH
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1191-9. PubMed ID: 12649307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different effects of fenfluramine isomers and metabolites on extracellular 5-HIAA in nucleus accumbens and hippocampus of freely moving rats.
    De Simoni MG; Juraszczyk Z; Fodritto F; De Luigi A; Garattini S
    Eur J Pharmacol; 1988 Aug; 153(2-3):295-9. PubMed ID: 2460361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intracerebroventricular administration of d-fenfluramine and d-norfenfluramine, as a single injection or 2-hr infusion, on serotonin in brain: relationship to concentrations of drugs in brain.
    Invernizzi R; Fracasso C; Caccia S; Garattini S; Samanin R
    Neuropharmacology; 1991 Feb; 30(2):119-23. PubMed ID: 2030819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of high-dose fenfluramine treatment on monoamine uptake sites in rat brain: assessment using quantitative autoradiography.
    Appel NM; Mitchell WM; Contrera JF; De Souza EB
    Synapse; 1990; 6(1):33-44. PubMed ID: 2144664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indan analogs of fenfluramine and norfenfluramine have reduced neurotoxic potential.
    Cozzi NV; Frescas S; Marona-Lewicka D; Huang X; Nichols DE
    Pharmacol Biochem Behav; 1998 Mar; 59(3):709-15. PubMed ID: 9512076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of behavioral activity by norfenfluramine and related drugs in rats is not mediated by serotonin release.
    Callaway CW; Wing LL; Nichols DE; Geyer MA
    Psychopharmacology (Berl); 1993; 111(2):169-78. PubMed ID: 7870948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences between d-fenfluramine and d-norfenfluramine in serotonin presynaptic mechanisms.
    Borroni E; Ceci A; Garattini S; Mennini T
    J Neurochem; 1983 Mar; 40(3):891-3. PubMed ID: 6827286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is receptor activation involved in the mechanism by which (+)-fenfluramine and (+)-norfenfluramine deplete 5-hydroxytryptamine in the rat brain?
    Invernizzi R; Kmieciak-Kolada K; Samanin R
    Br J Pharmacol; 1982 Mar; 75(3):525-30. PubMed ID: 6175368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. d-Fenfluramine- and d-norfenfluramine-induced hypophagia: differential mechanisms and involvement of postsynaptic 5-HT receptors.
    Gibson EL; Kennedy AJ; Curzon G
    Eur J Pharmacol; 1993 Sep; 242(1):83-90. PubMed ID: 8223940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal differences in behavioral effect of fenfluramine and norfenfluramine.
    Schechter MD
    Pharmacol Biochem Behav; 1990 Mar; 35(3):527-31. PubMed ID: 2339144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. d-fenfluramine, but not d-norfenfluramine, uses calcium to increase extracellular serotonin.
    Puig de Parada M; Parada MA; Pothos E; Hoebel BG
    Life Sci; 1995; 56(22):PL415-20. PubMed ID: 7746089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of repeated fenfluramine administration on indices of monoamine function in rat brain: pharmacokinetic, dose response, regional specificity and time course data.
    Zaczek R; Battaglia G; Culp S; Appel NM; Contrera JF; De Souza EB
    J Pharmacol Exp Ther; 1990 Apr; 253(1):104-12. PubMed ID: 2329498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of the anorectic agent, d-fenfluramine, and its primary metabolite, d-norfenfluramine, on intact human platelet serotonin uptake and efflux.
    Johnson GJ; Leis LA; Dunlop PC; Weir EK
    J Thromb Haemost; 2003 Dec; 1(12):2663-8. PubMed ID: 14675103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative activity of the enantiomers of fenfluramine and norfenfluramine in rodent seizure models, and relationship with their concentrations in plasma and brain.
    Erenburg N; Hamed R; Shaul C; Perucca E; Bialer M
    Epilepsia; 2023 Jun; 64(6):1673-1683. PubMed ID: 36995363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of d- and l-norfenfluramine following their administration as individual enantiomers in rats.
    Erenburg N; Hamed R; Shaul C; Barasch D; Perucca E; Bialer M
    Epilepsia; 2024 Feb; 65(2):e14-e19. PubMed ID: 38041575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of d-norfenfluramine in the indole-depleting effect of d-fenfluramine in the rat.
    Caccia S; Anelli M; Ferrarese A; Fracasso C; Garattini S
    Eur J Pharmacol; 1993 Mar; 233(1):71-7. PubMed ID: 7682511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications.
    Rothman RB; Baumann MH; Savage JE; Rauser L; McBride A; Hufeisen SJ; Roth BL
    Circulation; 2000 Dec; 102(23):2836-41. PubMed ID: 11104741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of fenfluramine to norfenfluramine in guinea-pigs.
    Fuller RW; Snoddy HD; Perry KW
    J Pharm Pharmacol; 1988 Jun; 40(6):439-41. PubMed ID: 2458444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.